EPITHELIAL OVARIAN CANCER
Clinical trials for EPITHELIAL OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new EPITHELIAL OVARIAN CANCER trials appear
Sign up with your email to follow new studies for EPITHELIAL OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted Antibody-Drug could shrink Hard-to-Treat ovarian cancers
Disease control Not yet recruitingThis trial tests a drug called sacituzumab govitecan in people with advanced or recurrent ovarian, fallopian tube, or primary peritoneal cancer that has high levels of a protein called TROP-2. Participants must have already tried standard treatments without success. The drug is g…
Matched conditions: EPITHELIAL OVARIAN CANCER
Phase: PHASE1 • Sponsor: Shanghai Gynecologic Oncology Group • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Personalized mRNA vaccine aims to train immune system against ovarian cancer
Disease control Not yet recruitingThis trial tests a personalized mRNA vaccine called NeoOVIV in people with stage II or III ovarian cancer who have had surgery. The vaccine is designed to teach the immune system to recognize and attack cancer cells. Participants receive the vaccine alongside standard chemotherap…
Matched conditions: EPITHELIAL OVARIAN CANCER
Phase: PHASE1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New hope for Platinum-Resistant ovarian cancer: BL-M07D1 enters phase 3 trial
Disease control Not yet recruitingThis Phase 3 trial compares a new drug called BL-M07D1 against standard chemotherapy in 404 people with HER2-expressing ovarian, fallopian tube, or peritoneal cancer that has become resistant to platinum-based treatment. Participants will receive either BL-M07D1 or one of several…
Matched conditions: EPITHELIAL OVARIAN CANCER
Phase: PHASE3 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Immunotherapy-Chemo combo before surgery shows promise for advanced ovarian cancer
Disease control Not yet recruitingThis phase 2 trial tests whether combining two immunotherapy drugs (iparomlimab and tuvonralimab) with standard chemotherapy before surgery can improve outcomes for people with advanced ovarian cancer. Participants receive 3-4 cycles of the combination, followed by surgery to rem…
Matched conditions: EPITHELIAL OVARIAN CANCER
Phase: PHASE2 • Sponsor: Obstetrics & Gynecology Hospital of Fudan University • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New hope for tough ovarian cancer: drug combo trial launches
Disease control Not yet recruitingThis study tests a combination of two drugs, liposomal irinotecan and enlonstobart, in 30 women with ovarian cancer that no longer responds to platinum chemotherapy. The goal is to see if the combo can shrink tumors and delay cancer growth. Participants receive treatment every tw…
Matched conditions: EPITHELIAL OVARIAN CANCER
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New drug senaparib tested in Real-World ovarian cancer study
Disease control Not yet recruitingThis study will observe 500 women with ovarian, fallopian tube, or primary peritoneal cancer who are taking the drug senaparib. Researchers will track side effects and how well the drug controls the cancer in real-world conditions, outside of a strict clinical trial. The goal is …
Matched conditions: EPITHELIAL OVARIAN CANCER
Sponsor: Zhejiang Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New drug cocktail aims to shrink ovarian tumors before surgery
Disease control Not yet recruitingThis Phase 2 trial will test a combination of the experimental drug QL1706 with standard chemotherapy or with olaparib and intraperitoneal chemotherapy as a pre-surgery treatment for 50 women with advanced ovarian cancer. The goal is to see if this approach can shrink tumors enou…
Matched conditions: EPITHELIAL OVARIAN CANCER
Phase: PHASE2 • Sponsor: Jiangsu Cancer Institute & Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Ovarian cancer trial uses KELIM score to personalize surgery timing
Disease control Not yet recruitingThis study looks at whether a blood test score (KELIM) can help doctors decide the best time for surgery in people with advanced ovarian cancer. After three rounds of chemotherapy, those with a good score will have surgery right away, while those with a poor score will get more c…
Matched conditions: EPITHELIAL OVARIAN CANCER
Phase: NA • Sponsor: Aristotle University Of Thessaloniki • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Can a common supplement fight chemo brain? new trial aims to find out
Symptom relief Not yet recruitingThis study tests whether N-Acetyl-Cysteine (NAC), a supplement, can reduce chemotherapy-related cognitive impairment (often called 'chemo brain') in ovarian cancer patients. About 102 postmenopausal women with advanced ovarian cancer receiving platinum-based chemotherapy will tak…
Matched conditions: EPITHELIAL OVARIAN CANCER
Phase: PHASE1, PHASE2 • Sponsor: University of California, Irvine • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
New dye technique could spare ovarian cancer patients from invasive surgery
Knowledge-focused Not yet recruitingThis study tests whether a dye called indocyanine green can help surgeons find cancer spread in early ovarian cancer. About 30 women will receive the dye during surgery to see if it can identify affected lymph nodes. If it works, it may reduce the need for removing many lymph nod…
Matched conditions: EPITHELIAL OVARIAN CANCER
Phase: NA • Sponsor: Başakşehir Çam & Sakura City Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Eye test for surgeons: can they spot cancer clues?
Knowledge-focused Not yet recruitingThis study checks if surgeons can tell key details about ovarian cancer by looking at images from a camera inside the belly. About 70-80 surgeons will review pictures from 19 patients and guess the cancer type and growth pattern. The goal is to see if visual clues can help plan t…
Matched conditions: EPITHELIAL OVARIAN CANCER
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC